Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| Jun 2 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 24,965 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 3,520 | $158.59 | $558.2K | -13.6% | Open the original filing on SEC.gov |
| Jun 2 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 9,521 | $157.62 | $1.5M | -26.9% | Open the original filing on SEC.gov |
| Jun 2 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 4,216 | $156.77 | $660.9K | -10.6% | Open the original filing on SEC.gov |
| Jun 2 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 5,466 | $155.46 | $849.7K | -12.1% | Open the original filing on SEC.gov |
| Jun 2 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 14,214 | $154.83 | $2.2M | -24.0% | Open the original filing on SEC.gov |
| Jun 2 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 24,965 | $81.49 | $2M | +72.7% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 4,754 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 27,100 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,510 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,401 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 5,378 | $124.12 | $667.5K | -13.6% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT | 9,968 | — | — | +33.7% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 815 | $124.12 | $101.2K | -2.7% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 1,510 | — | — | +5.2% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 756 | $124.12 | $93.8K | -2.5% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 1,401 | — | — | +5.0% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,387 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | FTAX | 749 | $123.10 | $92.2K | -2.6% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER | 1,387 | — | — | +5.0% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,741 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | FTAX | 997 | $136.06 | $135.7K | -3.5% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER | 1,741 | — | — | +6.5% | Open the original filing on SEC.gov |
| May 16, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 6,468 | — | — | — | Open the original filing on SEC.gov |
| May 16, 2025 | NBIX | Neurocrine Biosciences INC | MEXER | 6,468 | $61.82 | $399.9K | +31.7% | Open the original filing on SEC.gov |